FLT-3 expression and function on microglia in multiple sclerosis

Experimental and Molecular Pathology

Volumn 89, Issue 2, 2010, Pages 109-116

  DeBoy, Cynthia A ^a   Rus, Horea ^b   Tegla, Cosmin ^b   Cudrici, Cornelia ^b   Jones, Melina V ^a   Pardo, Carlos A ^a   Small, Donald ^c   Whartenby, Katharine A ^c   Calabresi, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; CD209 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 6; LESTAURTINIB; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; FLT3 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOSE RESPONSE; DRUG TARGETING; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; WHITE MATTER; ANIMAL; BRAIN; C57BL MOUSE; CYTOLOGY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FMS-LIKE TYROSINE KINASE 3; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MULTIPLE SCLEROSIS;

MURINAE;

EID: 77956422651     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.05.009     Document Type: Article

References (50)

1. Alliot F., Godin I., Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res. 1999, 117:145-152.
2. Aloisi F., Ria F., Columba-Cabezas S., Hess H., Penna G., Adorini L. Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naive CD4+ T cell priming and Th1/Th2 cell restimulation. Eur. J. Immunol. 1999, 29:2705-2714.
3. Barnett M.H., Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 2004, 55:458-468.
4. Becher B., Durell B.G., Noelle R.J. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J. Clin. Invest. 2003, 112:1186-1191.
5. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
6. Bjartmar C., Yin X., Trapp B.D. Axonal pathology in myelin disorders. J. Neurocytol. 1999, 28:383-395.
7. Block M.L., Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 2005, 76:77-98.
8. Carson M.J., Reilly C.R., Sutcliffe J.G., Lo D. Mature microglia resemble immature antigen-presenting cells. Glia 1998, 22:72-85.
9. Cudrici C., Ito T., Zafranskaia E., Niculescu F., Mullen K.M., Vlaicu S., Judge S.I., Calabresi P.A., Rus H. Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis. Exp. Mol. Pathol. 2007, 83:198-206.
10. De Groot C.J., Bergers E., Kamphorst W., Ravid R., Polman C.H., Barkhof F., van der Valk P. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001, 124:1635-1645.
11. Gottschall P.E., Yu X., Bing B. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J. Neurosci. Res. 1995, 42:335-342.
12. Gray E., Thomas T.L., Betmouni S., Scolding N., Love S. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol. 2008, 18:86-95.
13. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., Noelle R.J., Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005, 11:328-334.
14. Guo A.C., MacFall J.R., Provenzale J.M. Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology 2002, 222:729-736.
15. Heppner F.L., Greter M., Marino D., Falsig J., Raivich G., Hovelmeyer N., Waisman A., Rulicke T., Prinz M., Priller J., Becher B., Aguzzi A. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 2005, 11:146-152.
16. Hickey W.F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988, 239:290-292.
17. Ifergan I., Kebir H., Bernard M., Wosik K., Dodelet-Devillers A., Cayrol R., Arbour N., Prat A. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 2008, 131:785-799.
18. Jack C., Ruffini F., Bar-Or A., Antel J.P. Microglia and multiple sclerosis. J. Neurosci. Res. 2005, 81:363-373.
19. Juedes A.E., Ruddle N.H. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J. Immunol. 2001, 166:5168-5175.
20. Kaplin A.I., Deshpande D.M., Scott E., Krishnan C., Carmen J.S., Shats I., Martinez T., Drummond J., Dike S., Pletnikov M., Keswani S.C., Moran T.H., Pardo C.A., Calabresi P.A., Kerr D.A. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J. Clin. Invest. 2005, 115:2731-2741.
21. Kawakami N., Lassmann S., Li Z., Odoardi F., Ritter T., Ziemssen T., Klinkert W.E., Ellwart J.W., Bradl M., Krivacic K., Lassmann H., Ransohoff R.M., Volk H.D., Wekerle H., Linington C., Flugel A. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 2004, 199:185-197.
22. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
23. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Bruck W., Rauschka H., Bergmann M., Schmidbauer M., Parisi J.E., Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
24. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
25. Lassmann H. The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin. N. Am. 2008, 18:563-576. ix.
26. Levis M., Allebach J., Tse K.F., Zheng R., Baldwin B.R., Smith B.D., Jones-Bolin S., Ruggeri B., Dionne C., Small D. A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo. Blood 2002, 99:3885-3891.
27. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500-508.
28. Markovic A., MacKenzie K.L., Lock R.B. FLT-3: a new focus in the understanding of acute leukemia. Int. J. Biochem. Cell Biol. 2005, 37:1168-1172.
29. Matyszak M.K., Perry V.H. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 1996, 74:599-608.
30. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., Cua D.J. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
31. McMenamin P.G. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations. J. Comp. Neurol. 1999, 405:553-562.
32. Mendel I., Katz A., Kozak N., Ben-Nun A., Revel M. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 1998, 28:1727-1737.
33. Phuttharak W., Galassi W., Laopaiboon V., Laopaiboon M., Hesselink J.R. Abnormal diffusivity of normal appearing brain tissue in multiple sclerosis: a diffusion-weighted MR imaging study. J. Med. Assoc. Thai. 2007, 90:2689-2694.
34. Ponomarev E.D., Novikova M., Maresz K., Shriver L.P., Dittel B.N. Development of a culture system that supports adult microglial cell proliferation and maintenance in the resting state. J. Immunol. Meth. 2005, 300:32-46.
35. Ponomarev E.D., Shriver L.P., Maresz K., Dittel B.N. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci. Res. 2005, 81:374-389.
36. Potter E.G., Cheng Y., Knight J.B., Gordish-Dressman H., Natale J.E. Basic science; metallothionein I and II attenuate the thalamic microglial response following traumatic axotomy in the immature brain. J. Neurotrauma 2007, 24:28-42.
37. Quintana A., Muller M., Frausto R.F., Ramos R., Getts D.R., Sanz E., Hofer M.J., Krauthausen M., King N.J., Hidalgo J., Campbell I.L. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J. Immunol. 2009, 183:2079-2088.
38. Samoilova E.B., Horton J.L., Hilliard B., Liu T.S., Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 1998, 161:6480-6486.
39. Santambrogio L., Belyanskaya S.L., Fischer F.R., Cipriani B., Brosnan C.F., Ricciardi-Castagnoli P., Stern L.J., Strominger J.L., Riese R. Developmental plasticity of CNS microglia. Proc. Natl Acad. Sci. USA 2001, 98:6295-6300.
40. Sastre-Garriga J., Ingle G.T., Chard D.T., Ramio-Torrenta L., McLean M.A., Miller D.H., Thompson A.J. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch. Neurol. 2005, 62:569-573.
41. Serada S., Fujimoto M., Mihara M., Koike N., Ohsugi Y., Nomura S., Yoshida H., Nishikawa T., Terabe F., Ohkawara T., Takahashi T., Ripley B., Kimura A., Kishimoto T., Naka T. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 2008, 105:9041-9046.
42. Serafini B., Columba-Cabezas S., Di Rosa F., Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 2000, 157:1991-2002.
43. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Capello E., Mancardi G.L., Aloisi F. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 2006, 65:124-141.
44. Skarica M., Wang T., McCadden E., Kardian D., Calabresi P.A., Small D., Whartenby K.A. Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis. J. Immunol. 2009, 182:4192-4199.
45. Steinman L. Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 2008, 118:3557-3563.
46. Town T., Nikolic V., Tan J. The microglial "activation" continuum: from innate to adaptive responses. J. Neuroinflammation 2005, 2:24.
47. van der Valk P., Amor S. Preactive lesions in multiple sclerosis. Curr. Opin. Neurol. 2009, 22:207-213.
48. Vrenken H., Geurts J.J. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective. Expert Rev. Neurother. 2007, 7:271-279.
49. Weisel K.C., Yildirim S., Schweikle E., Kanz L., Mohle R. Effect of FLT3 inhibition on normal hematopoietic progenitor cells. Ann. N. Y. Acad. Sci. 2007, 1106:190-196.
50. Whartenby K.A., Calabresi P.A., McCadden E., Nguyen B., Kardian D., Wang T., Mosse C., Pardoll D.M., Small D. Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16741-16746.